Jeff L. Vacirca, Director at Odonate Therapeutics, Inc. (ODT), bought 3,000 shares at $17.00 ($51K) on 2019-03-04, disclosed to the SEC on 2019-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 1,000 | $17K | 33.3% |
| 2 | $17.00 | 2,000 | $34K | 66.7% |
| Total | $17.00 avg | 3,000 | $51K | 100% |
| Filing → |
| SPPI | BUY | 2022-12-02 | $23K | — | Filing → |
| ODT | BUY | 2019-06-28 | $500K | — | Filing → |
| ODT | BUY | 2017-12-14 | $23K | — | Filing → |